Physician Assistant Program year 2022 Reported 2021–2022 Source: CMS Open Payments, 2026 publication

Daniel Sellers

Physician Assistant Sarasota, FL Physician Assistant

NPI 1841693819 CMS profile 10673272

5741 Bee Ridge Rd Ste 530, Sarasota, FL 34233

Open in the dashboard

General payments

$119,983

381 records reported · program years 2021–2022

Research payments

$0

Paid to them · None reported · program years 2021–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Daniel Sellers of Sarasota, FL is reported in the CMS Open Payments database as having received $119,983 across 381 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $49,094 206
2021 General $70,889 175

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Sellers
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Daniel Sellers were reported at $0. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Daniel Sellers Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $70,889 $132 $37–$438 $132
2022 $49,094 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $0 $178 $55–$600 $164
2025 $0 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2022
  1. EMD Serono, Inc. $62,573 124 payments
  2. Biogen, Inc. $31,174 62 payments
  3. Genzyme Corporation $15,126 32 payments
  4. Celgene Corporation $4,074 25 payments
  5. E.R. Squibb & Sons, L.L.C. $3,243 7 payments
  6. Banner Life Sciences, LLC $813 6 payments
  7. TG Therapeutics, Inc. $765 1 payment
  8. Biohaven Pharmaceuticals, Inc. $524 28 payments
  9. Biohaven Pharmaceutical Holding Company Ltd. $296 37 payments
  10. Novartis Pharmaceuticals Corporation $239 19 payments
  11. Other $1,157 40 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $83,075 74 payments
  2. Travel and Lodging $14,665 45 payments
  3. Consulting Fee $13,865 13 payments
  4. Food and Beverage $8,027 244 payments
  5. Education $351 5 payments
Products named General payments · program years 2021–2022
  1. Mavenclad $58,236 95 payments
  2. VUMERITY $21,303 46 payments
  3. AUBAGIO $12,875 27 payments
  4. ZEPOSIA $6,220 30 payments
  5. PLEGRIDY $4,769 7 payments
  6. TYSABRI $1,242 16 payments
  7. NURTEC ODT $820 65 payments
  8. KESIMPTA $236 15 payments
  9. UBRELVY $184 8 payments
  10. PRODISC C VIVO $155 1 payment
  11. Other $851 47 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

381 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record